Gene Query: DEPDC5

Dataset Description Geneva Score
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.5
The pause-initiation limit restricts transcription activation in human cells 11.02
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.96
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.96
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 8.79
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 8.79
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 8.04
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.41
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.41
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 6.36
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.13
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 6.11
Landscape of H3K4me3 in human CD19 cells 5.29
Transcriptional profiles of normal human mature B cells 5.09
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 5.03
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 4.62
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 4.59
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 4.59
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.55
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.55
Seletive inhibition of CDK9 in DLBCL cell lines 4.48
Nutritional control of protein translation 4.03
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 4.01
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 3.97
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 3.89
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.86
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.79
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 3.74
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.49
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.47
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.47
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.38
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.35
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.12
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.12
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 3.11
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 3.06
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.02
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.0
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 3.0
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 2.98
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 2.92
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.75
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.75
MYCi975 regulates MYC target genes 2.72
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.7
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 2.7
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 2.7
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 2.62
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.61
Non-coding regions are the main source of tumor-specific antigens 2.5
Non-coding regions are the main source of tumor-specific antigens [human] 2.5
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.46
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.46
CD74 role in transcription regulation 2.42
CD74 role in transcription regulation [RNA-seq] 2.42
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 2.39
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 2.32
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 2.28
Tyrosine Kinase Inhibitor Cardiotoxicity 2.28
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.28
NRDE2 negatively regulates nuclear exosome functions 2.24
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 2.22
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.22
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 2.2
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 2.16
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 2.16
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.13
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.06
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.06
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.05
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.05
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 2.05
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.01
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 1.99
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.99
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.82
mRNA recovered upon RNF219 IP. [RNA-IP] 1.82
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.79
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.76
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.76
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.76
Gene expression analysis of immortalized human liver progenitor-like cells in culture 1.71
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.68
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.68
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.66
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.66
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 1.61
Intron retention induced by microsatellite expansions as a disease biomarker. 1.59
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 1.58
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.58
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.58
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.57
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 1.57
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 1.57
MYC dependent mRNA translation shapes gene expression and cell biology 1.54
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.53
Transcriptomic profiling of human peripheral blood-derived mast cells 1.53
Hepatosplenic T cell lymphoma 1.53
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.53
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.52
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.52
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.52
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 1.52
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.51
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 1.47
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.47
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.47
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.44
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 1.43
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.42
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.42
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 1.41
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 1.41
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 1.41
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 1.39
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 1.39
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 1.38
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 1.38
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.38
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.38
Modulation of nonsense-mediated decay by rapamycin 1.38
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.38
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.38
RNAseq Study in CC-671 Treated Cal-51 Cells 1.37
Differentially expressed genes post knock down of lincDUSP26 1.37
Dtx3L and Androgen Signaling in Prostate Cancer 1.37
U1 snRNP telescripting regulates size-function stratified human genome 1.36
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.35
Effect of PBK knockdown on C4-2 cell transcriptome 1.34
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 1.34
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 1.33
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 1.33
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.33
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.33
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 1.33
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.33
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.33
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.33
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.31
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.31
Landscape and variation of RNA secondary structure across the human transcriptome 1.3
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 1.29
Gene expression profile of human placenta from T. Cruzi infected mothers 1.29
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.29
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.29
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.28
Downregulation of DDX5/DDX17 and REST 1.28
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.27
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 1.24
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.24
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 1.23
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 1.23
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 1.22
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 1.21
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 1.21
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.21
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.21
Total RNA-Seq data from leukemic patients with complex structural variants 1.21
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.2
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.2
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.2
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.2
Effect of drugs on transcriptomic profiles 1.19
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 1.18
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.17
Gene expression in GBM with Cav3.2 inhibition 1.17
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.16
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.16
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.16
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 1.16
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.15
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.14
PRDM1 inhibits proliferation of human colon cancer organoids 1.14
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.13
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 1.13
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 1.13
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.13
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.12
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 1.12
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 1.12
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 1.12
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.12
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.11
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 1.11
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.1
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.1
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.1
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 1.1
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.09
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 1.09
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 1.09
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 1.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.09
RNA-Seq from human ILC transitional populations 1.09
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 1.08
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.07
Effect of CHKA knockdown on C4-2 cell transcriptome 1.07
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 1.05
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.05
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 1.05
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.04
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.04
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.04
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.04
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.03
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.02
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.02
miRNAs affected by antagomiR-17 treatment 1.01
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.01
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.01
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.01
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 1.01
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 1.01
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 1.0
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 1.0
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 1.0
Targeted enhancer activation by a subunit of the integrator complex 0.99
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.98
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 0.98
Human embryonic stem cells in E8 and AKIT culture medium 0.98
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.98
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.98
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 0.98
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 0.98
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 0.98
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 0.97
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.95
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 0.94
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 0.94
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.93
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.92
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 0.92
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.9
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.9
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.9
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 0.9
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.89
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 0.89
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.89
N6-methyladenine DNA Modification in Glioblastoma 0.89
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 0.89
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.87
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.87
Searching for target genes of miR-508/509/506/514 in HCT116 cells 0.87
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.87
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.87
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.85
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.85
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.85
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.84
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.84
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.84
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.84
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.84
RNA editing in nascent RNA affects pre-mRNA splicing 0.83
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 0.83
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.83
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.83
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.82
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.82
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.82
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.82
mRNA expression profile of Lymphocytes 0.81
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.8
CircRNAome diversity in human mature B-cells, T-cells and monocytes 0.78
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 0.77
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.77
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.77
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 0.76
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.75
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.74
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 0.74
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.73
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.73
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.72
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.72
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.72
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.71
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.7
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.7
Effect of PRDM11 depletion in U2932 cells 0.7
RNAseq analysis of ruxolitinib treated breast cancers 0.68
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.68
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.68
Discovering human diabetes-risk gene function with genetics and physiological assays 0.68
RNA-sequencing of formalin fixed human primary melanoma tissue 0.67
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.67
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.67
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 0.67
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.66
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.65
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 0.64
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 0.63
Transcriptional profile in human S. haematobium infection 0.62
Noncoding regions are the main source of targetable tumor-specific antigens 0.61
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.61
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.61
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.61
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.61
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.61
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.6
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.59
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.59
SNHG5 siRNA knock down in HCT116 cells 0.59
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.58
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.58
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 0.57
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.57
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 0.56
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.56
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.56
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 0.55
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 0.55
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.55
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.55
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.55
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.54
Global epigenomic reconfiguration during mammalian brain development 0.53
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 0.53
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.52
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.52
RNA sequencing of mechanically strained NHEKs and control NHEKs 0.52
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.52
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.52
Bone marrow derived human B cells [normal proB] 0.51
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.51
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.5
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 0.5
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 0.5
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 0.49
RNA-seq analysis of differentiating human erythroblasts 0.49
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.49
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.49
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.48
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.48
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.47
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.47
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.46
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.46
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.46
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.46
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.44
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.44
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.44
Transcriptome analysis of CNS leukemia 0.44
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.44
Be1 and Be2 B cells are transcriptionally distinct 0.44
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.43
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.43
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.43
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.43
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.43
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.42
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.41
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.41
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.41
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.41
Studying the selectivity of a small molecule Synucleozid on transcriptome 0.4
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.39
Characterization of human ILC2 subsets 0.39
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.39
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.38
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.38
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.38
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.38
The pioneer factor CEBPA modulates vitamin D signaling 0.38
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.38
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.37
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.37
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.37
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.36
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.36
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.36
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 0.36
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.36
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.36
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.35
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.35
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.34
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.34
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.34
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.33
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.33
Dysregulated immune system networks in war veterans with PTSD 0.33
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.31
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.31
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.3
High-resolution comparative analysis of great ape genomes 0.28
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.28
Expression patterns in chronic thromboembolic pulmonary hypertension 0.27
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.27
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.27
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.27
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.27
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.27
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.27
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.26
quanTIseq: quantifying immune contexture of human tumors 0.26
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.26
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.26
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 0.26
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.25
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.25
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.25
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.25
Gene expression activation in CLL mediated by MSCs contact 0.24
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.24
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.24
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.24
RNA-sequencing 0.24
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.24
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.23
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.23
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.22
Recovery and analysis of nascent RNA 0.22
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.22
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.22
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.22
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.21
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.21
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.21
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.21
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.21
Identification of a LIF-responsive replication-competent human β cell 0.2
Transcriptomic analysis of human macrophages in 3D 0.2
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.2
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.2
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.19
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.19
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.19
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.19
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.19
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.19
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 0.18
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.18
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.18
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.18
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.18
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.17
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.17
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.17
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.17
Deep RNA sequencing of the human placental transcriptome 0.16
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.15
Transcriptome analysis of SKI knock-out in HL60 cells 0.15
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.15
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.14
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.13
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.13
Functional significance of the HIV-1 Tat signature amino acid residues 0.13
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.12
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.12
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.12
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.11
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.11
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.11
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.11
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 0.11
The transcriptome and chromatin accessbility landscape of mammalian germline 0.1
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.09
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.09
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.08
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.08
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.08
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.08
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.07
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.07
ML29755 RNA-seq data 0.07
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.07
Transcriptome of human white and brown adipose tissue biopsies 0.06
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.06
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.06
Expression analysis of the TAF1 syndrome 0.06
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.06
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.06
Trascriptome of thyroid cancer-induced macrophages 0.06
Role of FGFR1 in neuronal devlopment 0.06
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.05
MicroRNA-125a-5p overexpression in human macrophages 0.05
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.05
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.05
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.04
Gene expression changes due to PARP knockdown in human cells 0.04
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.04
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.03
Gene expression analysis of human hepatocellular cancers 0.03
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.02
Loss of CREBBP results in gene expression repression in lymphoma cells 0.02
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.02
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.01
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.01
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.01
The role of m6A/m-RNA methylation in stress response regulation 0.0
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.0
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation